Pharmacists have been on the frontlines of the COVID-19 pandemic for nine months and counting. Constant developments in Congress and federal agencies have implications for pharmacists’ practices. This presentation will review the "then and now" of governmental action in response to the COVID-19 pandemic and the impact of legislation and regulations on provider status efforts and pharmacists’ scope of practice.
Describe the governmental action (legislative and regulatory) to address COVID-19 and the impact on pharmacists� practices.
List COVID-19 and non-COVID-19 examples of recent federal legislative activity that impact the practice of pharmacy.
Describe the latest COVID-19 and non-COVID-19 federal regulations related to the practice of pharmacy.